Moderna Inc. (MRNA)

Sector:Health Care
Super Investor Stats:
Ownership count:0
Ownership rank:--
% of all portfolios:0%
History Portfolio Manager Activity Share change % change to portfolio
Q2  2025
Duan Yongping - H&H International Investment Sell 100.00% 83,000 0.02
Q1  2025
Duan Yongping - H&H International Investment Reduce 49.08% 80,000 0.02
Q4  2024
Duan Yongping - H&H International Investment Add 66.84% 65,300 0.02
Q3  2024
Duan Yongping - H&H International Investment Reduce 30.56% 43,000 0.02
Q1  2024
Duan Yongping - H&H International Investment Add 0.14% 200 0.00
Q4  2023
Duan Yongping - H&H International Investment Add 35.10% 36,500 0.03
Q3  2023
Stephen Mandel - Lone Pine Capital Sell 100.00% 1,529,618 1.70
Duan Yongping - H&H International Investment Reduce 25.71% 36,000 0.03
Q2  2023
Duan Yongping - H&H International Investment Reduce 6.67% 10,000 0.01
Q1  2023
Stephen Mandel - Lone Pine Capital Add 13.09% 177,100 0.25
Duan Yongping - H&H International Investment Reduce 6.25% 10,000 0.01
Q4  2022
Stephen Mandel - Lone Pine Capital Buy 1,352,518 2.32
Q4  2021
Stephen Mandel - Lone Pine Capital Sell 100.00% 3,316,199 4.30
Q3  2021
Stephen Mandel - Lone Pine Capital Reduce 16.91% 674,698 0.87
Q2  2021
Stephen Mandel - Lone Pine Capital Buy 3,990,897 3.02
Q1  2021
Lee Ainslie - Maverick Capital Sell 100.00% 2,277 0.00
Q4  2020
Lee Ainslie - Maverick Capital Buy 2,277 0.00
Q2  2020
Viking Global Investors Sell 100.00% 994,886 0.16
Q1  2020
Viking Global Investors Reduce 70.05% 2,326,869 0.37
Q4  2019
Viking Global Investors Reduce 28.99% 1,356,026 0.12
Q3  2019
Viking Global Investors Reduce 42.94% 3,519,677 0.29
Q2  2019
Viking Global Investors Reduce 50.82% 8,470,408 0.56

* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.